FOLR1 and neoplasm: These findings may provide valuable information for the design of regimens for cancer chemotherapy as well as improving the ability to detect drug resistance before and after chemotherapy with cisplatin by monitoring changes of DNA methylation status and expression levels of small GTPases and FBP in clinical tumour specimens.